Location History:
- Bresso, IT (2013)
- Concorezzo, IT (2008 - 2016)
Company Filing History:
5 out of 247 
1 out of 8 
1 out of 850 
Years Active: 2008-2016
Title: The Innovative Contributions of Alberto Bernareggi
Introduction
Alberto Bernareggi is a notable inventor based in Concorezzo, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target proteasome activity. With a total of nine patents to his name, Bernareggi's work has the potential to impact the treatment of various diseases, including cancer.
Latest Patents
Among his latest patents is a groundbreaking invention titled "Proteasome inhibitors and methods of using the same." This invention provides boronic acid compounds, boronic esters, and compositions that can modulate apoptosis by inhibiting proteasome activity. These compounds and compositions are designed for use in methods of inducing apoptosis and treating diseases associated with proteasome activity. Another significant patent is for "Injectable pharmaceutical compositions of an anthracenedione derivative with anti-tumoral activity." This patent describes injectable pharmaceutical compositions containing 6,9-bis[(2-aminoethyl)amino]benzo[g]isoquinoline-5,10-dione dimaleate as the active ingredient, formulated as a lyophilized powder with carriers such as lactose and dextran, mixed with sodium chloride.
Career Highlights
Throughout his career, Bernareggi has worked with prominent companies in the pharmaceutical industry, including Cephalon, Inc. and CTI Biopharma Corp. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Bernareggi has collaborated with notable colleagues such as Ernesto Menta and Raffaella Bernardini. These partnerships have likely enhanced his research and development efforts, leading to the successful creation of his patented inventions.
Conclusion
Alberto Bernareggi's innovative work in the field of pharmaceuticals demonstrates his commitment to advancing medical science. His patents reflect a deep understanding of complex biological processes and a dedication to improving treatment options for serious diseases.